Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s)

Infection and Immunity

Volumn 67, Issue 6, 1999, Pages 2909-2915

  Coombes, Brian K ^a,b   Mahony, James B ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; THYMIDINE;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BACTERIAL GROWTH; CELL PROLIFERATION; CHLAMYDOPHILA PNEUMONIAE; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MACROPHAGE; MITOGENESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0033023633     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.6.2909-2915.1999     Document Type: Article

References (39)

1. Auge, N., I. Escargueil-Blanc, I. Lajoie-Mazenc, I. Suc, N. Andrieu-Abadie, M. T. Pieraggi, M. Chatelut, J. C. Thiers, J. P. Jaffrezou, G. Laurent, T. Levade, A. Negre-Salvayre, and R. Salvayre. 1998. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J. Biol. Chem. 273:12893-12900.
2. Byrne, G. I., and J. W. Moulder. 1978. Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells. Infect. Immun. 19:598-606.
3. Campbell, L. A., E. R. O'Brien, A. L. Cappuccio, C. C. Kuo, S. P. Wang, D. Stewart, D. L. Patton, P. K. Cummings, and J. T. Grayston. 1995. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172:585-588.
4. Fawaz, F., S. Mutka, and J. Engel. 1993. Chlamydia-host cell interaction, abstr. D-150, p. 121. In Abstracts of the 93rd General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
5. Fawaz, F. S., C. van Ooij, E. Homola, S. C. Mutka, and J. N. Engel. 1997. Infection with Chlamydia trachomatis alters the tyrosine phosphorylation and/or localization of several host cell proteins including cortactin. Infect. Immun. 65:5301-5308.
6. Fong, I. W., B. Chiu, E. Viira, M. W. Fong, D. Jang, and J. Mahony. 1997. Rabbit model for Chlamydia pneumoniae infection. J. Clin. Microbiol. 35: 48-52.
7. Galdiero, M., G. Cipolloaro de L'Ero, and A. Marcatili. 1997. Cytokine and adhesion molecule expression in human monocytes and endothelial cells stimulated with bacterial heat shock proteins. Infect. Immun. 65:699-707.
8. Gaydos, C. A., J. T. Summersgill, N. N. Sahney, J. A. Ramirez, and T. C. Quinn. 1996. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64:1614-1620.
9. Gibbs, R. G. J., N. Carey, and H. Davies. 1998. Chlamydia pneumoniae and vascular disease. Br. J. Surg. 85:1191-1197.
10. Godzik, K. L., E. R. O'Brien, S. K. Wang, and C. C. Kuo. 1995. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J. Clin. Microbiol. 33:2411-2414.
11. Grayston, J. T., S. P. Wang, C. C. Kuo, and L. A. Campbell. 1989. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur. J. Clin. Microbiol. Infect. Dis. 8:191-202.
12. Gupta, S., E. W. Leatham, D. Carrington, M. A. Mendall, J. C. Kaski, and J. Camm. 1997. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96:404-407.
13. Gurfinkel, E., G. Bozovich, A. Daroca, E. Beck, B. Mautner, and ROXIS Study Group. 1997. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 350:404-407.
14. Heinemann, M., M. Susa, U. Simnacher, R. Marre, and A. Essig. 1996. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect. Immun. 64:4872-4875.
15. Ishida, A., T. Sasaguri, C. Kosaka, H. Nojima, and J. Ogata. 1997. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J. Biol. Chem. 272:10050-10057.
16. Jackson, L. A., L. A. Campbell, C. C. Kuo, D. I. Rodriguez, A. Lee, and J. T. Grayston. 1997. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J. Infect. Dis. 176:292-295.
17. Kalayoglu, M. V., and G. I. Byrne. 1998. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect. Immun. 66:5067-5072.
18. Kaukoranta-Tolvanen, S. S., T. Ronni, M. Leinonen, P. Saikku, and K. Laitinen. 1996. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb. Pathog. 21:407-411.
19. Kol, A., G. K. Sukhova, A. H. Lichtman, and P. Libby. 1998. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumour necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98:300-307.
20. Kuo, C.-C., A. Shor, L. A. Campbell, H. Fukushi, D. L. Patton, and J. T. Grayston. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:841-849.
21. Kuo, C.-C., A. M. Gown, E. P. Benditt, and J. T. Grayston. 1993. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler. Thromb. 13:1501-1504.
22. Kuo, C.-C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
23. Linnanmaki, E., M. Leinonen, K. Matilla, M. S. Nieminen, V. Valtonen, and P. Saikku. 1993. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heat disease. Circulation 87:1130-1134.
24. Melnick, S., E. Shahar, A. R. Folsom, J. T. Grayston, P. D. Sorlie, and S. P. Wang. 1993. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) investigators. Am. J. Med. 95:499-504.
25. Moazed, T. C., C.-C. Kuo, J. T. Grayston, and L. A. Campbell. 1997. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J. Infect. Dis. 175:883-890.
26. Molestina, R. E., D. Dean, R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1998. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect. Immun. 66:1370-1376.
27. Muhlestein, J. B., J. L. Anderson, E. H. Hammond, L. Zhao, S. Trehan, E. P. Schwobe, and J. F. Carlquist. 1998. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97:633-636.
28. Navab, M., A. M. Fogelman, J. A. Berliner, M. C. Territo, L. L. Demer, J. S. Frank, A. D. Watson, P. A. Edwards, and A. J. Lusis. 1995. Pathogenesis of atherosclerosis. Am. J. Cardiol. 76:18C-23C.
29. Porreca, E., C. DiFebbo, M. Reale, M. L. Castellani, G. Baccante, R. Barbacane, P. Conti, F. Cuccurullo, and A. Poggi. 1997. Monocyte chemotactic protein 1 is a mitogen for cultured rat vascular smooth muscle cells. J. Vasc. Res. 34:58-65.
30. Ramirez, J., S. Ahkee, J. Summersgill, B. Ganzer, L. Ogden, T. Quinn, C. Gaydos, L. Bobo, M. Hammerschlag, P. Roblow, W. Lebar, J. Grayston, L. Campbell, D. Patton, D. Dean, and J. Schachter. 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann. Intern. Med. 125:979-982.
31. Roblin, P. M., W. Dunornay, and M. R. Hammerschlag. 1992. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 30:1968-1971.
32. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362:801-808.
33. Ross, R., and J. A. Glomset. 1973. Atherosclerosis and the arterial smooth muscle cell. Science 180:1332-1339.
34. Saikku, P. 1993. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur. Heart J. 14(Suppl. K):62-65.
35. Saikku, P., K. Mattila, M. S. Nieminen, J. K. Huttunen, M. Leinonen, M. R. Ekman, P. H. Makela, and V. Valtonen. 1988. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii:983-985.
36. Scidmore, M. A., D. D. Rockey, E. R. Fischer, R. A. Heinzen, and T. Hackstadt. 1996. Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. Infect. Immun. 64:5366-5372.
37. Stary, H. C. 1990. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur. Heart J. 11(Suppl. E):3-19.
38. Wang, X., T. L. Yue, E. H. Ohlstein, C. P. Sung, and G. Z. Feuerstein. 1996. Interferon inducible protein-10 involves vascular smooth muscle cell migration, proliferation and inflammatory response. J. Biol. Chem. 271:24286-24293.
39. Zhang, Z.-D., and G. Cox. 1996. MTT assay overestimates human airway smooth muscle cell number in culture. Biochem. Mol. Biol. Int. 38:431-436.